VENTURE CAPITAL POST

ConvaTec's owners have appointed Morgan Stanley (MS.N) and Goldman Sachs (GS.N) to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.

John Cannon was declared as ConvaTec's acting CFO.